153 related articles for article (PubMed ID: 20502005)
1. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis.
Becker KA; Grassmé H; Zhang Y; Gulbins E
Cell Physiol Biochem; 2010; 26(1):57-66. PubMed ID: 20502005
[TBL] [Abstract][Full Text] [Related]
2. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
[TBL] [Abstract][Full Text] [Related]
3. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Lüth A; Döring G; Kleuser B; Gulbins E
Am J Respir Cell Mol Biol; 2010 Jun; 42(6):716-24. PubMed ID: 19635928
[TBL] [Abstract][Full Text] [Related]
4. Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis.
Yu H; Zeidan YH; Wu BX; Jenkins RW; Flotte TR; Hannun YA; Virella-Lowell I
Am J Respir Cell Mol Biol; 2009 Sep; 41(3):367-75. PubMed ID: 19168701
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
Becker KA; Tümmler B; Gulbins E; Grassmé H
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
[TBL] [Abstract][Full Text] [Related]
6. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
Grassmé H; Becker KA; Zhang Y; Gulbins E
Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
[TBL] [Abstract][Full Text] [Related]
7. Ceramide in cystic fibrosis.
Grassmé H; Riethmüller J; Gulbins E
Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the inflammasome by ceramide in cystic fibrosis lungs.
Grassmé H; Carpinteiro A; Edwards MJ; Gulbins E; Becker KA
Cell Physiol Biochem; 2014; 34(1):45-55. PubMed ID: 24977480
[TBL] [Abstract][Full Text] [Related]
9. Ceramide mediates lung fibrosis in cystic fibrosis.
Ziobro R; Henry B; Edwards MJ; Lentsch AB; Gulbins E
Biochem Biophys Res Commun; 2013 May; 434(4):705-9. PubMed ID: 23523785
[TBL] [Abstract][Full Text] [Related]
10. Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis.
Gardner AI; Wu Y; Verhaegh R; Liu Y; Wilker B; Soddemann M; Keitsch S; Edwards MJ; Haq IJ; Kamler M; Becker KA; Brodlie M; Gulbins E
J Biol Chem; 2021; 296():100650. PubMed ID: 33839155
[TBL] [Abstract][Full Text] [Related]
11. The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.
Becker KA; Riethmüller J; Zhang Y; Gulbins E
Open Respir Med J; 2010 Mar; 4():39-47. PubMed ID: 20556203
[TBL] [Abstract][Full Text] [Related]
12. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts.
Grassmé H; Jendrossek V; Riehle A; von Kürthy G; Berger J; Schwarz H; Weller M; Kolesnick R; Gulbins E
Nat Med; 2003 Mar; 9(3):322-30. PubMed ID: 12563314
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase.
Managò A; Becker KA; Carpinteiro A; Wilker B; Soddemann M; Seitz AP; Edwards MJ; Grassmé H; Szabò I; Gulbins E
Antioxid Redox Signal; 2015 May; 22(13):1097-110. PubMed ID: 25686490
[TBL] [Abstract][Full Text] [Related]
14. Role of CD95 in pulmonary inflammation and infection in cystic fibrosis.
Becker KA; Henry B; Ziobro R; Tümmler B; Gulbins E; Grassmé H
J Mol Med (Berl); 2012 Sep; 90(9):1011-23. PubMed ID: 22314624
[TBL] [Abstract][Full Text] [Related]
15. Ceramide and sphingosine in pulmonary infections.
Seitz AP; Grassmé H; Edwards MJ; Pewzner-Jung Y; Gulbins E
Biol Chem; 2015 Jun; 396(6-7):611-20. PubMed ID: 25720061
[TBL] [Abstract][Full Text] [Related]
16. Fenretinide corrects newly found ceramide deficiency in cystic fibrosis.
Guilbault C; De Sanctis JB; Wojewodka G; Saeed Z; Lachance C; Skinner TA; Vilela RM; Kubow S; Lands LC; Hajduch M; Matouk E; Radzioch D
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):47-56. PubMed ID: 17656682
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids as targets for inhalation treatment of cystic fibrosis.
Becker KA; Riethmüller J; Seitz AP; Gardner A; Boudreau R; Kamler M; Kleuser B; Schuchman E; Caldwell CC; Edwards MJ; Grassmé H; Brodlie M; Gulbins E
Adv Drug Deliv Rev; 2018 Aug; 133():66-75. PubMed ID: 29698625
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in
Schiumarini D; Loberto N; Mancini G; Bassi R; Giussani P; Chiricozzi E; Samarani M; Munari S; Tamanini A; Cabrini G; Lippi G; Dechecchi MC; Sonnino S; Aureli M
Mediators Inflamm; 2017; 2017():1730245. PubMed ID: 29333001
[TBL] [Abstract][Full Text] [Related]
19. Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease.
Brodlie M; McKean MC; Johnson GE; Gray J; Fisher AJ; Corris PA; Lordan JL; Ward C
Am J Respir Crit Care Med; 2010 Aug; 182(3):369-75. PubMed ID: 20395562
[TBL] [Abstract][Full Text] [Related]
20. β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial Infections.
Grassmé H; Henry B; Ziobro R; Becker KA; Riethmüller J; Gardner A; Seitz AP; Steinmann J; Lang S; Ward C; Schuchman EH; Caldwell CC; Kamler M; Edwards MJ; Brodlie M; Gulbins E
Cell Host Microbe; 2017 Jun; 21(6):707-718.e8. PubMed ID: 28552668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
